Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.

Abstract: Waterborne aqueous-alcohol soluble protein compositions, methods of making the compositions, and applications thereof are disclosed. The dispersion compositions include protein, water, acid, and optionally an ester of a carboxylic acid. The methods of making the compositions including combining the protein, water, acid and optionally ester to form a dispersion without the benefit of alcohol. Applications include industrial and food applications, such as binders and coatings, for example paint binders or coatings for paper products and pharmaceuticals.

Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.

Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.

Abstract: This invention refers to the synthesis and purification of 2 hydroxide derivatives of fatty acids, as well as to the separation method of its enantiomers (or optic isomers) [?] y [+], to the enantiomers themselves, to pharmaceutical compositions which include them, and to their use as medicines, as well as to an in vitro method of diagnosis/prognosis and evaluation of the potential use of the molecules of the invention in different pathologies, as well as their use for the regulation of certain enzymes and the study of their activity and effects.

Abstract: Waterborne aqueous-alcohol soluble protein compositions, methods of making the compositions, and applications thereof are disclosed. The dispersion compositions include protein, water, acid, and optionally an ester of a carboxylic acid. The methods of making the compositions including combining the protein, water, acid and optionally ester to form a dispersion without the benefit of alcohol. Applications include industrial and food applications, such as binders and coatings, for example paint binders or coatings for paper products and pharmaceuticals.

Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.

Abstract: This invention refers to the synthesis and purification of 2 hydroxide derivatives of fatty acids, as well as to the separation method of its enantiomers (or optic isomers) [?] y [+], to the enantiomers themselves, to pharmaceutical compositions which include them, and to their use as medicines, as well as to an in vitro method of diagnosis/prognosis and evaluation of the potential use of the molecules of the invention in different pathologies, as well as their use for the regulation of certain enzymes and the study of their activity and effects.

Abstract: The present invention relates to a biopolymer, bioactive and totally biocompatible, very fluid at ambient temperature, capable of gelling in a sudden manner at 37° C., forming a solid implant, structurally integral and continuous having high mechanical properties. The biopolymer comprises at least a bioactive domain capable of directing in a precise manner the formation of a solid or semisolid implant. Furthermore the invention relates to any of the nucleic acids encoding the amino acid sequence of the biopolymer, implants, pharmaceutically acceptable vehicles, uses thereof, and a method of synthesis thereof.

Abstract: The present invention relates to a biopolymer, bioactive and totally biocompatible, very fluid at ambient temperature, capable of gelling in a sudden manner at 37° C., forming a solid implant, structurally integral and continuous having high mechanical properties. The biopolymer comprises at least a bioactive domain capable of directing in a precise manner the formation of a solid or semisolid implant. Furthermore the invention relates to any of the nucleic acids encoding the amino acid sequence of the biopolymer, implants, pharmaceutically acceptable vehicles, uses thereof, and a method of synthesis thereof.

Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.

Abstract: A container assembly includes at least one container and a base. The container includes a hollow body and a lid. The body comprises a sidewall and a bottom, wherein the sidewall circumscribes the bottom. The body sidewall includes a shoulder circumscribing the body. At least a portion of the lid includes a transparent material. The lid is removably coupled to the body such that a cavity is defined by the body and the lid. The lid includes a base portion and a sidewall circumscribing the base portion and extending therefrom. The shoulder is for positioning the lid with respect to the body. At least one of the body and the lid is fabricated from a paper-based material. The container bottom is magnetically coupled to the base.

Abstract: A spice rack assembly includes a rack and at least one container that is magnetically coupled to the rack. The at least one container comprises a body and a lid. The body comprises a sidewall and a bottom, wherein the sidewall circumscribes the bottom. The lid is coupled to the body such that a cavity is defined by an inner surface of the lid, an inner surface of the sidewall, and an inner surface of the bottom. The container sidewall comprises an opening extending therethrough in flow communication with the cavity.

Abstract: A process is provided in which at least one polyol having a hydroxyl functionality of at least three, preferably four, serves as a polymerization initiator. The polyol initiator is optionally, although preferably, reacted with a catalyst to form a catalyst-initiator complex, which is then used in the polymerization of glycidyl nitrate. The resulting polyfunctional poly(glycidyl nitrate) has a functionality substantially equivalent in number to the hydroxyl functionality of the polyol. The poly(glycidyl nitrate) is cross-linked with at least one aromatic diisocyanate having at least one aromatic ring and two isocyanate moieties bonded directly to the at least one aromatic ring. Examples of the aromatic diisocyanate include toluene diisocyanate, phenylene diisocyanate, and/or methylene di-p-phenylene diisocyanate.

Abstract: A plastic article is formed in an injection mold by injecting molten plastic into the injection mold at an elevated temperature, cooling the plastic from the molten condition to a solid condition, and crystallizing a portion of the plastic by slowing down the cooling of said portion.

Abstract: A plastic article is formed in an injection mold by injecting molten plastic into the injection mold at an elevated temperature, cooling the plastic from the molten condition to a solid condition, and crystallizing a portion of the plastic by slowing down the cooling of said portion.

Abstract: A plastic article is formed in an injection mold by injecting molten plastic into the injection mold at an elevated temperature, cooling the plastic from the molten condition to a solid condition, and crystallizing a portion of the plastic by slowing down the cooling of said portion.

Abstract: A plastic article is formed in an injection mold by injecting molten plastic into the injection mold at an elevated temperature, cooling the plastic from the molten condition to a solid condition, and crystallizing a portion of the plastic by slowing down the cooling of said portion.

Abstract: A plastic article is formed in an injection mold by injecting molten plastic into the injection mold at an elevated temperature, cooling the plastic from the molten condition to a solid condition, and crystallizing a portion of the plastic by slowing down the cooling of said portion.